‘We are better together’: IPA broadens scope to cover Postbiotics, Prebiotics, Synbiotics

By Stephen Daniells

- Last updated on GMT

© DrAfter123 / Getty Images
© DrAfter123 / Getty Images

Related tags Probiotics Prebiotics postbiotics synbiotics International probiotics association Unmetered Unmetered

The International Probiotics Association has announced it is expanding its scope to cover a broad range of ‘biotics’ in response to industry growth and market demand.

The announcement came after a meeting of the IPA Board of Directors (BoD) following the sold out IPA World Congress + Probiota in Barcelona last week, which attracted almost 500 stakeholders from across the biotics spectrum.

“We will continue our solid path of driving and upholding the probiotic category as we replicate our past achievements in these biotic categories,”​ wrote George Paraskevakos in a message to IPA members this week.

“To emulate the successes of the probiotic category, IPA BoD will start work on building the required frameworks and organizational structure for the expanded scope that will enable an intentional and fruitful future for the probiotics industry. It is a natural progression for the evolution of IPA, and we are delighted to announce this strategic focus.”

The organization is exploring a rebranding to cover these categories but no further information is available at this time.

The announcement is not a surprise to industry watchers after Paraskevakos hinted at such a move during an interview with NutraIngredients-USA at SupplySide West 2022​.

“Because these categories so nicely complement the probiotics market, the BoD has spent many months optimizing a strategy to help the probiotics industry grow in response to market demands; this includes a scope expansion, intended to focus on the ‘biotics’,” ​added Paraskevakos in the member memo. “In no way will this impede our focused efforts regarding the probiotics category. In fact, it will only strengthen our ownership within these ‘biotic’ categories.”

New President & staff changes

IPA also announced that Dr Amy Smith has been elected Interim President following the departure of Kevin Mehring from IPA and Chr Hansen. Dr Smith has occupied several IPA roles, as committee chair and as vice-president of the BoD.

Commenting on the expanded scope, Dr Smith told NutraIngredients: “We are better together.”

Supporting the scope expansion, IPA announced that Meryl Massot will transition to a new role titled ‘Project Coordinator and Committee Support’. Ms Massot joined IPA last summer, and her new role will ensure the continuity of committee engagement and project planning.

Massot’s former role as Member and Events Coordinator will be filled by Ms. Kristina Paraskevakos, who has previously supported IPA on a part-time basis.

Widget

Linked resource

Lumina Report

POSTbiotics – New Tools in Microbiome Modulation

In this report, Lumina Intelligence analyses the evolving opportunity on POSTbiotics, examining key players, trends, and target consumers in over 20 countries.

Widget

Discounted Reports

Lumina Report

Lumina Intelligence Discounted Report Bundle

Dive into Lumina Intelligence reports on Probiotics for Pets, POSTbiotics, and a Smooth Menopause Transition. Limited time offer—empower yourknowledge now!

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Explore the capabilities with PlexoZome®

Explore the capabilities with PlexoZome®

Content provided by Gencor | 11-Aug-2023 | White Paper

Explore the capabilities PlexoZome® offers for your formulation.

Pharmako Biotechnologies, Gencor’s sister company, developed PlexoZome®,...

Related suppliers

Follow us

Products

View more

Webinars

Nutra Champions Podcast

Nutra Champions Podcast